Forecasting the quantity and cost of medicines to treat non-communicable diseases in low- and middle-income countries: Applying knowledge on medicine use from developed countries

Res Social Adm Pharm. 2017 Jan-Feb;13(1):257-258. doi: 10.1016/j.sapharm.2016.07.009. Epub 2016 Aug 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Developed Countries*
  • Developing Countries / economics*
  • Drug Costs
  • Drug Therapy / economics*
  • Humans
  • Noncommunicable Diseases / drug therapy*
  • Noncommunicable Diseases / economics*
  • Poverty*
  • World Health Organization